Avidity Biosciences, Inc. (RNA)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

6

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
23-Sep-24 9:01 PM View:	23-Sep-24 Sale (Planned) ($1.45M)	Boyce Sarah President and CEO Director		Avidity Biosciences, Inc. - RNA	36% 172.16K to 234.66K	0	0	--	--	Show Txns Hide Txns

23-Sep-24 8:59 PM View:	23-Sep-24 Sale (Planned) ($506.44K)	MacLean Michael F Chief Financial Officer		Avidity Biosciences, Inc. - RNA	35% 71.36K to 96.36K	0	0	--	--	Show Txns Hide Txns

09-Oct-24 5:23 PM View:	07-Oct-24 Option Sale ($1.35M)	Thompson Tamar Director		Avidity Biosciences, Inc. - RNA	0% --	0	0	--	--	Show Txns Hide Txns

20-Nov-24 6:10 PM View:	18-Nov-24 Planned Option Sale ($1.03M)	McCarthy Teresa Chief Human Resources Officer		Avidity Biosciences, Inc. - RNA	64% 57.17K to 94.02K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 6:06 PM View:	19-Nov-24 Planned Option Sale ($139.97K)	Levin Arthur A Director		Avidity Biosciences, Inc. - RNA	(13%) 168.7K to 146.2K	0	0	--	--	Show Txns Hide Txns

03-Oct-24 4:09 PM View:	01-Oct-24 Planned Option Sale ($2.98M)	Flanagan W. Michael CSTO		Avidity Biosciences, Inc. - RNA	13% 75.77K to 85.39K	0	0	--	--	Show Txns Hide Txns